Biora Therapeutics, Inc. Total Liabilities
Biora Therapeutics, Inc. had Total Liabilities of $121.13 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2024-11-14
- 2024-09-30: Liabilities $121.13M.
- 2024-06-30: Liabilities $107.58M.
- 2024-03-31: Liabilities $123.17M.
- 2023-12-31: Liabilities $132.64M.
| Period end | Liabilities |
|---|---|
| 2024-09-30 | $121.13M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $107.58M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $123.17M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $132.64M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $153.49M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $170.55M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $158.24M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $155.81M 10-K · filed 2024-04-01 |
| 2022-09-30 | $160.06M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $173.21M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $179.92M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $193.81M 10-K · filed 2023-03-30 |
| 2021-09-30 | $274.65M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $259.56M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $254.08M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $261.43M 10-K · filed 2022-03-28 |
| 2020-09-30 | $180.04M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $203.58M 10-Q · filed 2020-08-14 |
| 2019-12-31 | $185.60M 10-K · filed 2021-03-18 |